IO Biotech Inc (IOBT)
1.24
+0.06
(+5.17%)
USD |
NASDAQ |
Jun 25, 16:00
1.31
+0.07
(+5.65%)
After-Hours: 07:22
IO Biotech Total Assets (Quarterly): 128.16M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 128.16M |
| December 31, 2023 | 150.72M |
| September 30, 2023 | 172.55M |
| June 30, 2023 | 117.56M |
| March 31, 2023 | 136.84M |
| December 31, 2022 | 151.80M |
| September 30, 2022 | 162.16M |
| Date | Value |
|---|---|
| June 30, 2022 | 182.64M |
| March 31, 2022 | 202.17M |
| December 31, 2021 | 222.29M |
| September 30, 2021 | 52.04M |
| June 30, 2021 | 58.53M |
| December 31, 2020 | 5.653M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.653M
Minimum
Dec 2020
222.29M
Maximum
Dec 2021
134.09M
Average
150.72M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.69M |
| Shareholders Equity (Quarterly) | 115.47M |